Leslie Tari - Mar 15, 2024 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: CHIEF SCIENTIFIC OFFICER
Signature: /s/ Shane Ward, Attorney-in-Fact
Stock symbol: CDTX
Transactions as of: Mar 15, 2024
Transactions value $: $0
Form type: 4
Date filed: 3/20/2024, 06:47 PM
Previous filing: Mar 12, 2024
Next filing: Sep 13, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDTX	Common Stock	Award	$0	+111K	+43.01%	$0.00	370K	Mar 15, 2024	Direct	F1
holding	CDTX	Common Stock						1.48K	Mar 15, 2024	By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDTX	Employee Stock Option (right to buy)	Award	$0	+223K		$0.00	223K	Mar 15, 2024	Common Stock	223K	$0.68	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents time-based Restricted Stock Units (RSUs) granted on March 15, 2024. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2025, 2026, and 2027, subject to continuous service through each such vesting date.
F2	The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 15, 2024.